Alaunos Therapeutics(TCRT)
盘后2.23-0.05-2.19%19:56 EDT
2.28-0.76-25.00%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Alaunos Therapeutics所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Alaunos Therapeutics, Inc.最初于1998年9月在科罗拉多州注册成立，后来在特拉华州重新注册成立。该公司是一家临床前阶段的生物制药公司，专注于开发用于治疗肥胖症及相关代谢紊乱（包括代谢功能障碍相关的脂肪肝）的新型口服小分子疗法。该项目旨在开发一种差异化的、非激素、非肠促胰岛素的治疗方法，这与 GLP-1 类药物等激素疗法截然不同。- 10-23 12:00Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-21Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-09Form 8-K - Current report重要事件披露Form 8-K - Current report
- 09-22Form 8-K - Current report重要事件披露Form 8-K - Current report
- 09-17Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 07-03Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 06-29Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-26Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 05-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 04-30Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend][修订]年度报告Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 04-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 03-31Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
2.86
今开
2.83
量比
0.08
最低
2.18
昨收
3.04
换手率
111.28%